Biomerieux SA
F:EYW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomerieux SA
F:EYW
|
FR |
|
G
|
Geron Corp
F:GON
|
US |
|
Lifecare AS
F:LFC
|
NO |
|
M
|
Marsh & McLennan Companies Inc
DUS:MSN
|
US |
|
XBiotech Inc
F:4XB
|
US |
|
E
|
Eventbrite Inc
F:EB4
|
US |
|
A
|
Ananda Development PCL
SET:ANAN
|
TH |
|
C
|
Cyberark Software Ltd
F:CYB
|
IL |
|
Boyd Group Services Inc
F:3YT
|
CA |
|
P
|
Pan Asia Footwear PCL
SET:PAF
|
TH |
|
G
|
Galp Energia SGPS SA
ELI:GALP
|
PT |
|
K
|
Kandenko Co Ltd
F:5EY
|
JP |
Wall St Price Targets
EYW Price Targets Summary
Biomerieux SA
According to Wall Street analysts, the average 1-year price target for EYW is 277.094 EUR with a low forecast of 203.65 EUR and a high forecast of 408.055 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EYW's stock price target?
Price Target
277.094
EUR
According to Wall Street analysts, the average 1-year price target for EYW is 277.094 EUR with a low forecast of 203.65 EUR and a high forecast of 408.055 EUR.
What is the Revenue forecast for Biomerieux SA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 6%.
What is the Operating Income forecast for Biomerieux SA?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 5 years is 11%.
What is the Net Income forecast for Biomerieux SA?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 5 years is 16%.
